Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Positioning within the framework of the SARS-CoV-2 (COVID-19) pandemic G. Miranda-Zazueta; J.A. González-Regueiro; I. García-Juárez; C. Moctezuma-Velázquez; F.J. López-Díaz; B. Pérez-González; L.F. Uscanga-Domínguez; M. Peláez-Luna;

Weight change and lifestyle modifications implemented during the COVID-19 pandemic lockdown are associated with the development of gastrointestinal symptoms F. Higuera-de-la-Tijera; A. Servín-Caamaño; F. Lajud-Barquín; A. Tovar-Aguilar;

Impact of time to esophagogastroduodenoscopy in patients with nonvariceal upper gastrointestinal bleeding: A systematic review and meta-analysis H.G. Bilder; C. Soccini; J.S. Lasa; I. Zubiaurre;